Cybin Inc. Common Stock (HELP) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.1x

Market Cap

$892.80M

MomentumView details →

1D Return

+3.82%

YTD Return

+47.49%

RSI (14)

57.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−4.1x

Market Cap

$892.80M

RSI (14)

57.7

MomentumView details →

1D Return

+3.82%

YTD Return

+47.49%

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−75.79%

ROA (TTM)

−70.67%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+7.24%

FCF YoY

−58.74%

Revenue CAGR 3Y

—

EPS CAGR 3Y

+24.33%

EBITDA YoY

−19.90%

EarningsView details →

EPS (Actual)

−$0.91

EPS Surprise

−8.84%

Beats (12Q)

2/12

Next Q EPS Est

−$0.71

Avg Surprise (4Q)

−31.18%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

10.97x

Quick Ratio

10.97x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−183.27M

Op. CF (TTM)

−152.97M

Next earningsNov 12, 2026 →

Latest newsMore news →

No recent news for HELP.

Similar companies

Climb Bio, Inc.CLYM Theravance Biopharma, Inc.TBPH Silence Therapeutics plcSLN Rigel Pharmaceuticals, Inc.RIGL Achieve Life Sciences, Inc.ACHV CANbridge Pharmaceuticals Inc.01228.HK Find similar companies →

Latest newsMore news →

No recent news for HELP.